We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $521B
1-Year Est. Return 51.41%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+30.53%
1 Year Est. Return
+51.41%
3 Year Est. Return
+144.39%
5 Year Est. Return
+179.66%
10 Year Est. Return
+692.6%
AUM
$521B
AUM Growth
+$105B
Cap. Flow
-$13.2B
Cap. Flow %
-2.54%
Top 10 Hldgs %
42.95%
Holding
5,723
New
722
Increased
1,729
Reduced
2,511
Closed
392

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$4.58B
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.74B
3
AAPL icon
Apple
AAPL
+$1.66B
4
AMD icon
Advanced Micro Devices
AMD
+$1.3B
5
AMZN icon
Amazon
AMZN
+$1.23B

Sector Composition

Rank Sector Weight
1 Miscellaneous 55.34%
2 Technology 17.88%
3 Financials 5.92%
4 Consumer Discretionary 4.3%
5 Communication Services 3.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCSI icon
4001
Consensus Cloud Solutions
CCSI
$666M
$94.7K ﹤0.01%
2,482
-1,543
-38% -$46.2K
HAWK
4002
HawkEye 360 Inc
HAWK
$1.75B
$94.5K ﹤0.01%
+4,674
New +$129K
JYNT icon
4003
The Joint Corp
JYNT
$116M
$94.3K ﹤0.01%
10,735
-2,141
-17% -$18.9K
CNNE icon
4004
Cannae Holdings
CNNE
$674M
$93.8K ﹤0.01%
6,515
-4,066
-38% -$55.3K
TNXP icon
4005
Tonix Pharmaceuticals
TNXP
$226M
$93.7K ﹤0.01%
7,346
+797
+12% +$10.3K
FHTX icon
4006
Foghorn Therapeutics
FHTX
$287M
$93.6K ﹤0.01%
19,189
-244
-1% -$1.08K
GAPR icon
4007
FT Vest US Equity Moderate Buffer ETF April
GAPR
$294M
$93.2K ﹤0.01%
2,236
TDACW
4008
Translational Development Acquisition Corp Warrants
TDACW
$15.9M
$93K ﹤0.01%
+70,492
New +$70.7K
VOXR
4009
Vox Royalty Corp
VOXR
$398M
$92.8K ﹤0.01%
19,618
-678
-3% -$3.73K
MVIS icon
4010
Microvision
MVIS
$51.1M
$92.8K ﹤0.01%
18,911
+15,064
+392% +$124K
FBRX
4011
DELISTED
Forte Biosciences
FBRX
$92.7K ﹤0.01%
4,362
-8,906
-67% -$211K
ARCT icon
4012
Arcturus Therapeutics
ARCT
$444M
$92.6K ﹤0.01%
13,775
+145
+1% +$1.14K
DMAC icon
4013
DiaMedica Therapeutics
DMAC
$353M
$92.5K ﹤0.01%
13,145
+6,658
+103% +$40.9K
FHDG
4014
FT Vest U.S. Equity Quarterly Dynamic Buffer ETF
FHDG
$71.5M
$92.3K ﹤0.01%
2,546
FEBT icon
4015
AllianzIM U.S. Equity Buffer10 Feb ETF
FEBT
$160M
$92.1K ﹤0.01%
+2,238
New +$90K
AVO icon
4016
Mission Produce
AVO
$1.14B
$91.9K ﹤0.01%
7,791
-4,302
-36% -$54.3K
OVID icon
4017
Ovid Therapeutics
OVID
$537M
$91.8K ﹤0.01%
34,120
+34,119
+3,411,900% +$88K
ELMT
4018
The Elmet Group
ELMT
$516M
$91.7K ﹤0.01%
+4,647
New +$79.8K
GOOD
4019
Gladstone Commercial Corp
GOOD
$634M
$91.7K ﹤0.01%
7,452
-13,200
-64% -$164K
SPIB icon
4020
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.6B
$91.5K ﹤0.01%
2,736
DDFO
4021
Innovator Equity Dual Directional 15 Buffer ETF - October
DDFO
$101M
$91.5K ﹤0.01%
4,065
+3,510
+632% +$78K
RYAM icon
4022
Rayonier Advanced Materials
RYAM
$578M
$91.2K ﹤0.01%
11,601
-769
-6% -$6.97K
PFIS icon
4023
Peoples Financial Services
PFIS
$711M
$91.1K ﹤0.01%
1,372
-687
-33% -$40.7K
PBYI icon
4024
Puma Biotechnology
PBYI
$485M
$90.8K ﹤0.01%
11,202
-2,786
-20% -$20.4K
SABR icon
4025
Sabre
SABR
$912M
$90.8K ﹤0.01%
43,438
-27,315
-39% -$47.9K

Similar funds

Barclays's Q2 2026 Portfolio in Review

As of Q2 2026, Barclays held 5,723 positions worth $521B, up 25% from $416B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Barclays's Q2 2026 filing shows 722 new, 1,729 increased, 2,511 reduced and 392 closed positions. Its largest new stake was Honeywell Aerospace: 2,302,561 shares worth $509M. The largest sale was NVIDIA, an estimated $4.58B.

By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, up from 46% a quarter earlier, followed by Technology and Financials.

  • Barclays's largest Q2 2026 buy was Honeywell Aerospace: 2,302,561 shares worth $509M.
  • Barclays added most to iShares MSCI Emerging Markets ETF in Q2 2026, an estimated $14.1B increase.
  • Barclays's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $4.58B.
  • Barclays fully exited Masimo in Q2 2026, selling an estimated $488M.
  • Barclays's ten largest holdings make up 43% of its $521B portfolio in Q2 2026.
  • Barclays opened 722 new positions and closed 392 in Q2 2026.
  • Barclays's portfolio value rose 25% quarter-over-quarter to $521B.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.